China regulator confesses invalid tests; GE recalls dangerous ventilators; Pfizer recalls cough syrup;

> The FDA says Pfizer ($PFE) is voluntarily recalling its Robitussin DM cough syrup because of dosing inaccuracies for children. Story

> The FDA has assigned its most serious designation to GE Healthcare's ($GE) recall of Aestiva/5 7900, warning that a flaw in the devices could lead to circulatory shock and death. Story

> The FDA smacked Siemens Healthcare with the second warning letter in a month concerning quality and manufacturing issues with some of its diagnostics products. Story

> An FDA 483 inspection of Exemplar Pharmaceuticals of Fall River, MA, found the aerosol drugmaker lacked adequate controls to ensure consistent mixtures of its products. FDA report

And Finally... A Chinese agency acknowledged that invalid testing led it to say that vanillin had been found in baby formula from companies including Mead Johnson. Story

Suggested Articles

Teva will produce its new migraine drug at a plant in Israel and more news of note.

The shortage of childhood cancer drug vincristine was front and center during the Senate hearing for Stephen Hahn, nominee for FDA commissioner.

The FDA has lambasted the Torrent Pharmaceuticals in a warning letter for making OTC meds using water tainted with bacteria.